Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Williams

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Advances in Therapy|July 3, 2003
Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertensionRobert J Noecker, Melissa L Earl, Tom Mundorf, et al.
Leukemia Research|July 6, 2004
Chromosomal aberrations in human lymphocytes exposed to the anticholinesterase pesticide isofenphos with mechanisms of leukemogenesisRobert D Williams, Laszlo G Boros, Christopher J Kolanko, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 17, 2008
A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprostElizabeth D Sharpe, Robert D Williams, Jeanette A Stewart, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 4, 2025
Double-Masked Controlled Trial of H-1337 as a Treatment for Glaucoma and Ocular HypertensionLee Shettle, Jay Mulaney, Robert D Williams, et al.
Advances in Therapy|August 17, 2006
A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucomaMonte S Dirks, Robert J Noecker, Melissa Earl, et al.
Nutrients|October 23, 2021
Untargeted Metabolomic Analysis of Human Milk from Mothers of Preterm InfantsLila S Nolan, Angela N Lewis, Qingqing Gong, et al.
Frontiers in Immunology|March 3, 2020
Monomeric C-Reactive Protein in Serum With Markedly Elevated CRP Levels Shares Common Calcium-Dependent Ligand Binding Properties With an <i>in vitro</i> Dissociated Form of C-Reactive ProteinRobert D Williams, Jennifer A Moran, Anthony A Fryer, et al.
The Journal of Biological Chemistry|June 11, 2003
Activation mechanism of the CO sensor CooA. Mutational and resonance Raman spectroscopic studiesCandace M Coyle, Mrinalini Puranik, Hwan Youn, et al.
Molecular Therapy. Nucleic Acids|April 19, 2021
Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencingCharles E Holjencin, Colton R Feinberg, Travis Hedrick, et al.
Neuropharmacology|June 14, 2006
Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal functionJudith A Siuciak, Sheryl A McCarthy, Douglas S Chapin, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Advances in Therapy|July 3, 2003
Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertensionRobert J Noecker, Melissa L Earl, Tom Mundorf, et al.
Leukemia Research|July 6, 2004
Chromosomal aberrations in human lymphocytes exposed to the anticholinesterase pesticide isofenphos with mechanisms of leukemogenesisRobert D Williams, Laszlo G Boros, Christopher J Kolanko, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 17, 2008
A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprostElizabeth D Sharpe, Robert D Williams, Jeanette A Stewart, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 4, 2025
Double-Masked Controlled Trial of H-1337 as a Treatment for Glaucoma and Ocular HypertensionLee Shettle, Jay Mulaney, Robert D Williams, et al.
Advances in Therapy|August 17, 2006
A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucomaMonte S Dirks, Robert J Noecker, Melissa Earl, et al.
Nutrients|October 23, 2021
Untargeted Metabolomic Analysis of Human Milk from Mothers of Preterm InfantsLila S Nolan, Angela N Lewis, Qingqing Gong, et al.
Frontiers in Immunology|March 3, 2020
Monomeric C-Reactive Protein in Serum With Markedly Elevated CRP Levels Shares Common Calcium-Dependent Ligand Binding Properties With an <i>in vitro</i> Dissociated Form of C-Reactive ProteinRobert D Williams, Jennifer A Moran, Anthony A Fryer, et al.
The Journal of Biological Chemistry|June 11, 2003
Activation mechanism of the CO sensor CooA. Mutational and resonance Raman spectroscopic studiesCandace M Coyle, Mrinalini Puranik, Hwan Youn, et al.
Molecular Therapy. Nucleic Acids|April 19, 2021
Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencingCharles E Holjencin, Colton R Feinberg, Travis Hedrick, et al.
Neuropharmacology|June 14, 2006
Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal functionJudith A Siuciak, Sheryl A McCarthy, Douglas S Chapin, et al.
Pageof 3